Copyright
©The Author(s) 2025.
World J Hepatol. Aug 27, 2025; 17(8): 109093
Published online Aug 27, 2025. doi: 10.4254/wjh.v17.i8.109093
Published online Aug 27, 2025. doi: 10.4254/wjh.v17.i8.109093
Table 1 Prevalence of hepatic osteodystrophy according to the aetiologies of liver disease
Disease | Ref. | n | Age (Year) | Post-menopausal (% of women) | Cirrhosis (%) | Osteoporosis prevalence |
Alcoholic liver disease | Kim et al[14], 2003 | 18 | 50 | 0 | 0 | 22 |
Wilson disease | Weiss et al[7], 2015 | 14 | 36 | NR | 38 | 9 |
HBV disease | Schiefke et al[15], 2005 | 13 | 49 | NR | 18 | 15 |
HCV disease | Schiefke et al[15], 2005 | 30 | 49 | NR | 18 | 20 |
MAFLD | Lee et al[9], 2016 | 6634 | Men > 40 and postmenopausal women | 50 | NR | 3.3% (male), 10.4 % (female) |
Primary biliary cirrhosis | Seki et al[16], 2017 | 128 | 61 | 100 | 0 | 26 |
- Citation: Pramanik S, Palui R, Ray S. Hepatic osteodystrophy: An underrecognized metabolic bone disease. World J Hepatol 2025; 17(8): 109093
- URL: https://www.wjgnet.com/1948-5182/full/v17/i8/109093.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i8.109093